SKYE BIOSCIENCE INC (SKYE) Stock Analyst Ratings
USA - NASDAQ:SKYE - US83086J2006 - Common Stock
1.51 USD
+0.09 (+6.34%)
1.51 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to SKYE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.89. This target is 488.65% above the current price.
SKYE was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SKYE.
In the previous month the buy percentage consensus was at a similar level.
SKYE was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-08-15 | Evercore ISI Group | Initiate | Outperform |
| 2025-06-24 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-21 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-21 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-02-28 | William Blair | Initiate | Outperform |
| 2024-09-30 | ScotiaBank | Initiate | Sector Outperform |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-20 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-10 | JMP Securities | Initiate | Market Outperform |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-07-09 | Craig-Hallum | Initiate | Buy |
| 2024-07-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-23 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-04-12 | Oppenheimer | Initiate | Outperform |
SKYE BIOSCIENCE INC / SKYE FAQ
What is the price target for SKYE stock?
13 analysts have analysed SKYE and the average price target is 8.89 USD. This implies a price increase of 488.65% is expected in the next year compared to the current price of 1.51.
What is the consensus rating for SKYE stock?
The consensus rating for SKYE BIOSCIENCE INC (SKYE) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover SKYE BIOSCIENCE INC (SKYE) stock?
The number of analysts covering SKYE BIOSCIENCE INC (SKYE) is 13.